Healthc Inform Res.  2021 Apr;27(2):95-101. 10.4258/hir.2021.27.2.95.

Future and Development Direction of Digital Healthcare

• Kim HS
• Kwon IH
• Cha WC

• KMID: 2515911
• DOI: http://doi.org/10.4258/hir.2021.27.2.95

Abstract

Objectives
Digital healthcare is expected to play a pivotal role in patient-centered healthcare. It empowers patients by informing, communicating, and motivating them. However, a pragmatic evaluation of the present status of digital healthcare has not been presented; therefore, we aimed to examine the status of digital healthcare in Korea.
Methods
This article discusses digital healthcare, examples of assessment in Korea and other countries, the implications of past examples, and future directions for development.
Results
Over the years, various clinical studies have used clinical evidence to assess the feasibility of digital healthcare. If feasible, it is actually clinically effective. If it is effective, can it be commercialized at an acceptable cost? These questions have been investigated in various evidence-based studies. In addition, great efforts are being made to secure ample evidence to assess various aspects of digital healthcare, such as safety, quality, end-user experience, and equity.
Conclusions
Digital healthcare requires a deep understanding of both the technical and medical aspects. To strengthen the competence of the medical aspect, medical staff, patients, and the government must work together with continuous interest in this goal.

Keyword

Delivery of Health Care; Health Information Systems; Remote Consultation; Telemedicine; Telecommunications

Figure

• 

  Figure 1 Digital healthcare service classification system for case survey. DTC: direct-to-customer.

Reference

References

1. Park MI, Yoo JB. Clinical application of tape-recorder and telemetry system for analysis of fetal heart rate. Korean J Obstet Gynecol. 1991; 34:915–26.

2. Park MI, Hwang YY, Chung SR, Lee JA, Park JI, Koo MK. Fetal heart rate telemetry system for monitoring of high risk pregnancies. Korean J Perinatol. 1998; 9:159–64.

3. Kim HS. Decision-making in artificial intelligence: is it always correct? J Korean Med Sci. 2020; 35:e1.

4. Digital Diagnostics Inc. History of digital diagnostics [Internet]. Coralville (IA): Digital Diagnostics Inc;c2020. [cited at 2021 Mar 30]. Available from: https://dxs.ai/about/history/ .

5. Digital Diagnostics Inc. New CPT code for automated point-of-care retinal imaging [Internet]. Coralville (IA): Digital Diagnostics Inc;c2020. [cited at 2021 Mar 30]. Available from: https://dxs.ai/newsroom/new-cpt-code-for-automated-point-of-care-retinal-imaging/ .

6. Shah A, Clarida W, Amelon R, Hernaez-Ortega MC, Navea A, Morales-Olivas J, et al. Validation of automated screening for referable diabetic retinopathy with an autonomous diagnostic artificial intelligence system in a Spanish population. J Diabetes Sci Technol. 2020. Mar. 16. [Epub]. http://doi.org/10.1177/1932296820906212 .

7. Abramoff MD, Lavin PT, Birch M, Shah N, Folk JC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. 2018; 1:39.

8. Jang JW. VUNO: Korea’s first ‘AI-based Diagnostic Assistant Medical Device’ license [Internet]. Seoul, Korea: Biospectator;c2018. [cited at 2021 Mar 30]. Available from: http://www.biospectator.com/view/news_view.php?varAtcId=5485 .

9. Kwon JM, Lee Y, Lee Y, Lee S, Park J. An algorithm based on deep learning for predicting in-hospital cardiac arrest. J Am Heart Assoc. 2018; 7:e008678.

10. Kwon JM, Lee SY, Jeon KH, Lee Y, Kim KH, Park J, et al. Deep learning-based algorithm for detecting aortic stenosis using electrocardiography. J Am Heart Assoc. 2020; 9:e014717.

11. Kang DY, Cho KJ, Kwon O, Kwon JM, Jeon KH, Park H, et al. Artificial intelligence algorithm to predict the need for critical care in prehospital emergency medical services. Scand J Trauma Resusc Emerg Med. 2020; 28:17.

12. Park S, Ahn CH, Jung G, Lee S, Paeng K, Shin J, et al. Deep learning-based predictive biomarker for immune checkpoint inhibitor response in metastatic non-small cell lung cancer. J Clin Oncol. 2019; 37(15_suppl):9094.

13. Lunit Inc. Medical Publications [Internet]. Seoul, Korea: Lunit;c2020. [cited at 2020 Oct 31]. Available from: https://www.lunit.io/ko/evidence/ai-research .

14. Pear Therapeutics Inc. Pear obtains FDA clearance of the first prescription digital therapeutic to treat disease [Internet]. Boston (MA): Pear Therapeutics Inc;2017. [cited at 2021 Mar 30]. Available from: https://peartherapeutics.com/fda-obtains-fda-clearance-first-prescription-digital-therapeutic-treat-disease/ .

15. Pear Therapeutics Inc. Pear Therapeutics announces first participant enrolled in virtual real-world study of adults with chronic insomnia [Internet]. Boston (MA): Pear Therapeutics Inc;c2020. [cited at 2021 Mar 30]. Available from: https://peartherapeutics.com/pear-therapeutics-announces-first-participant-enrolled-in-virtual-real-world-study-of-adults-with-chronic-insomnia/ .

16. Pear Therapeutics Inc. Product pipeline [Internet]. Boston (MA): Pear Therapeutics Inc;c2021. [cited at 2021 Mar 30]. Available from: https://peartherapeutics.com/science/product-pipeline/ .

17. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program (DPP) [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases;c2020. [cited at 2021 Mar 30]. Available from: https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/diabetes-prevention-program-DPP .

18. Moin T, Damschroder LJ, AuYoung M, Maciejewski ML, Havens K, Ertl K, et al. Results from a trial of an online diabetes prevention program intervention. Am J Prev Med. 2018; 55:583–91.

19. Sepah SC, Jiang L, Ellis RJ, McDermott K, Peters AL. Engagement and outcomes in a digital Diabetes Prevention Program: 3-year update. BMJ Open Diabetes Res Care. 2017; 5:e000422.

20. Jung SW. Continuous Glucose Monitoring System (CGMS) covered by health insurance [Internet]. Seoul, Korea: Newspim;2020. [cited at 2021 Mar 30]. Available from: https://www.newspim.com/news/view/20200114001060 .

21. Kumar RB, Goren ND, Stark DE, Wall DP, Longhurst CA. Automated integration of continuous glucose monitor data in the electronic health record using consumer technology. J Am Med Inform Assoc. 2016; 23:532–7.

22. US Securities and Exchange Commission. Amendment No. 3 to Form S-1 Registration Statement under the Securities Act of 1933 [Internet]. Washington (DC): US Securities and Exchange Commission;2015. [cited at 2021 Mar 30]. Available from: https://www.sec.gov/Archives/edgar/data/1477449/000104746915005538/a2225135zs-1a.htm .

23. Teladoc Health Inc. Teladoc blazes a trail in the emerging virtual telehealth services industry [Internet]. Purchase (NY): Teladoc Health Inc;2016. [cited at 2021 Mar 30]. Available from: https://ir.teladochealth.com/news-and-events/investor-news/press-release-details/2016/Teladoc-blazes-a-trail-in-the-emerging-virtual-telehealth-services-industry/default.aspx .

24. Versel N. Seven things we learned from the Teladoc IPO registration [Internet]. New York (NY): MedCityNews;c2015. [cited at 2021 Mar 30]. Available from: https://medcitynews.com/2015/05/seven-things-we-learned-from-the-teladoc-ipo-registration/ .

25. Noah B, Keller MS, Mosadeghi S, Stein L, Johl S, Delshad S, et al. Impact of remote patient monitoring on clinical outcomes: an updated meta-analysis of randomized controlled trials. NPJ Digit Med. 2018; 1:20172.

26. AliveCor Inc. AliveCor receives first FDA clearance to detect a serious heart condition in an ECG on a mobile device [Internet]. Mountain View (CA): Alive-Cor Inc;2014. [cited at 2021 Mar 30]. Available from: https://www.alivecor.com/press/press_release/alivecor-receives-first-fda-clearance-to-detect-a-serious-heart-condition-in-an-ecg-on-a-mobile-device/ .

27. Choi YS. A study on the ECG measurement of Apple Watch 4 [Internet]. Seoul, Korea: YoonSup Choi’s Healthcare Innovation;c2018. [cited at 2021 Mar 30]. Available from: https://www.yoonsupchoi.com/2018/09/21/apple-watch4-ecg/ .

28. Begley S. FDA approves first direct-to-consumer test for breast cancer risk [Internet]. Boston (MA): STAT;2018. [cited at 2021 Mar 30]. Available from: https://www.stat-news.com/2018/03/06/fda-approves-test-breast-cancer/ .

29. Global Digital Health Partnership. Evidence and evaluation [Internet]. New Delhi, India: Global Digital Health Partnership;c2020. [cited at 2021 Mar 30]. Available from: https://gdhp.nhp.gov.in/home/EvidenceEvaluation .

30. Kim HS, Shin JA, Chang JS, Cho JH, Son HY, Yoon KH. Continuous glucose monitoring: current clinical use. Diabetes Metab Res Rev. 2012; 28(Suppl 2):73–8.

31. Kim HS, Lee KH, Kim H, Kim JH. Using mobile phones in healthcare management for the elderly. Maturitas. 2014; 79:381–8.

32. Kim HS, Sun C, Yang SJ, Sun L, Li F, Choi IY, et al. Randomized, open-label, parallel group study to evaluate the effect of Internet-based glucose management system on subjects with diabetes in China. Telemed J E Health. 2016; 22:666–74.

33. Jung SH, Kim JW, Kang IK, Park CY, Kim YS, Woo JT. Continuous glucose monitoring is needed to detect unrecognized hypoglycemic event in diabetic patients with stroke. J Korean Diabetes. 2002; 3:140–51.